Vast Granted Qualified Infectious Disease Product Designation from the FDA
Hand-out
Press Releases
Vast Therapeutics, Inc.  
March 25, 2025

Vast Granted Qualified Infectious Disease Product Designation from the FDA

Advantages can accelerate making ALX1 drug candidate available to patients

logo salamanca press

Salamanca Press

Local & Social